Patient Square Capital Completes Acquisition of Premier, Inc.
Patient Square Capital has completed its $2.6 billion acquisition of Premier, Inc., a technology-driven healthcare improvement company. As a result, Premier's common stock ceased trading and will be delisted from Nasdaq, with stockholders receiving $28.25 in cash per share. This transaction marks a significant development for both companies in the healthcare investment sector.
Premier, Inc. Stockholders Overwhelmingly Approve Acquisition by Patient Square Capital
Premier, Inc. (NASDAQ: PINC) stockholders have overwhelmingly approved the acquisition of the company by an affiliate of Patient Square Capital. Approximately 99% of shares voted were in favor of the transaction, which is expected to close on or about November 25, 2025. Stockholders will receive $28.25 in cash per share, representing a 23.8% premium.
Premier, Inc. Reports Fiscal-Year 2026 First-Quarter Financial Results
Premier, Inc. reported its fiscal-year 2026 first-quarter financial results, with total net revenue decreasing 3% to $240.0 million and GAAP net income from continuing operations at $15.3 million ($0.21 per diluted share). Adjusted EBITDA declined 12% to $55.0 million and adjusted EPS decreased 12% to $0.30. Due to its pending acquisition by Patient Square Capital, Premier has withdrawn its fiscal-year 2026 guidance and will not host a conference call.
Premier : Weighs in on Section 232 Investigation into Medical Devices and Tariffs - MarketScreener
Premier Inc. submitted comments on a Section 232 investigation into medical device and PPE imports, cautioning against rapid tariff implementation due to potential cost increases and shortages. The company advocated for a targeted approach, distinguishing essential medical devices, and a gradual implementation timeline to allow manufacturers and healthcare providers to adapt, while also urging the study of tariff impacts and the use of alternative supply chain resiliency mechanisms.
Premier, Inc. to Report Fiscal 2026 First Quarter Results on November 4, 2025 - MarketScreener
Premier, Inc. (NASDAQ: PINC) announced it will release its fiscal 2026 first-quarter financial results on November 4, 2025, at approximately 6:30 a.m. ET. Due to its pending acquisition by Patient Square Capital, the company will not host a conference call to discuss these results. Premier, Inc. is a technology-driven health care improvement company, noted for its role in uniting healthcare providers, suppliers, and payers.
Premier, Inc. to Report Fiscal 2026 First Quarter Results on November 4, 2025 - The Joplin Globe
Premier, Inc. will report its fiscal 2026 first-quarter results on November 4, 2025. Due to its pending acquisition by Patient Square Capital, Premier will not host a conference call to discuss these financial results. The announcement also provides background information about Premier, Inc. as a technology-driven healthcare improvement company.
Inspire Investing LLC Has $1.24 Million Position in Premier, Inc. $PINC
Inspire Investing LLC significantly increased its stake in Premier, Inc. by 214.4% to $1.24 million, as other institutional investors also increased their holdings. Premier recently announced a quarterly dividend of $0.21 per share, resulting in a 3.0% yield, despite a high payout ratio of 381.82%. Analyst sentiment from Robert W. Baird shows a "neutral" rating with an increased target price of $27.00.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
Brodsky & Smith is notifying investors about ongoing investigations into the proposed acquisitions of Premier, Inc., Metsera, Inc., Anywhere Real Estate Inc., and The ODP Corporation. The investigations concern whether the respective Boards breached their fiduciary duties by failing to ensure fair processes and deal consideration for shareholders. Investors are encouraged to contact Brodsky & Smith to discuss these investigations without obligation.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
Brodsky & Smith is notifying investors of investigations into several companies due to concerns that their respective Boards may have breached fiduciary duties to shareholders during acquisition processes. The firms under investigation include Premier, Inc. (PINC), Metsera, Inc. (MTSR), Anywhere Real Estate Inc. (HOUS), and The ODP Corporation (ODP). Shareholders are invited to contact Brodsky & Smith to discuss these investigations without cost or obligation.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
Brodsky & Smith is investigating potential breaches of fiduciary duties by the boards of Premier, Inc. (PINC), Metsera, Inc. (MTSR), Anywhere Real Estate Inc. (HOUS), and The ODP Corporation (ODP). These investigations concern whether the proposed acquisitions of these companies offer fair value to their respective shareholders. Shareholders are encouraged to contact Brodsky & Smith to discuss these investigations without obligation.
$2.6B Healthcare Tech Deal: Premier Being Acquired by Patient Square Capital at 24% Premium
Premier, Inc., a healthcare improvement company, announced it will be acquired by Patient Square Capital for $2.6 billion. Stockholders will receive $28.25 per share in cash, a 23.8% premium. The acquisition is expected to enhance Premier's financial flexibility and accelerate its product portfolio advancement.
Patient Square Capital to Buy Premier Inc. in $2.6 Billion Deal
Patient Square Capital has agreed to acquire Premier Inc., a provider of healthcare improvement solutions, in a deal valued at approximately $2.6 billion. The investment firm will pay $28.25 per share in cash for the Charlotte, N.C.-based company, representing a 9.7% premium over its previous closing price. This marks Patient Square Capital's second acquisition of a public company this year.
Patient Square Capital Affiliate To Acquire Premier Inc.
Premier, Inc. (PINC) has reached a definitive agreement to be acquired by an affiliate of Patient Square Capital. Under the terms of the agreement, Premier stockholders will receive $28.25 in cash per share. Following the completion of the acquisition, Premier will become a private company, and its common stock will no longer be publicly traded.
Premier, Inc. Announces Definitive Agreement to Be Acquired by Patient Square Capital in Transaction Valued at $2.6 Billion
Premier, Inc. has announced a definitive agreement to be acquired by an affiliate of Patient Square Capital for $2.6 billion. Premier stockholders will receive $28.25 per share in cash, representing a 23.8% premium to the company's 60-day volume-weighted average price as of September 5, 2025. The transaction, unanimously approved by Premier's Board, is expected to close by the first quarter of calendar year 2026, after which Premier will become a private company.
Inmar Intelligence awarded pharmacy claims reconciliation and DSCSA compliance agreements with Premier, Inc.
Inmar Intelligence has secured new national group purchasing agreements with Premier, Inc. for critical pharmacy services. These agreements, effective July 2025, will provide Premier healthcare members with access to Inmar's automated pharmacy claims reconciliation platform and expanded DSCSA compliance solutions, including special pre-negotiated pricing and terms. The partnership aims to help pharmacies improve revenue performance, ensure regulatory readiness, and enhance operational efficiency through advanced technology and data insights.
Vestis Receives 2025 Supplier Legacy Award from Premier, Inc.
Vestis Corporation received the 2025 Supplier Legacy Award from Premier, Inc. for its exceptional service, value, and commitment to Premier's members. This award recognizes Vestis's long-standing support through local customer service, value creation, and efforts to lower costs for healthcare organizations. Vestis was among 14 suppliers honored, chosen by Premier member committees, highlighting its trusted collaboration and best-in-class service.
Vestis Receives 2025 Supplier Legacy Award from Premier, Inc.
Vestis Corporation announced it received the 2025 Supplier Legacy Award from Premier, Inc., recognizing its exceptional service, value, and commitment to Premier's members. One of only 14 recipients, Vestis was honored for its long-standing support, local customer service, value creation, and efforts in cost reduction. The award highlights Vestis's dedication to quality and trust within the B2B uniform and workplace supplies sector.
Patient Square Capital to Acquire Premier Inc. in $2.6 Bn Deal
Patient Square Capital, a healthcare investment firm, is set to acquire Premier Inc. in a $2.6 billion deal, taking the group purchasing, technology, and intelligence organization private. Premier stockholders will receive $28.25 per share, representing a 23.8% premium. The transaction, expected to close by Q1 2026, aims to provide financial flexibility and accelerate product portfolio advancement for Premier, which serves over two-thirds of U.S. healthcare providers.
Premier CCO Brailo sells $168,176 in PINC stock
Premier, Inc.'s Chief Commercial Officer, Andy Brailo, sold 6,521 shares of Class A Common Stock for $168,176 on September 3, 2025. This transaction was executed under a Rule 10b5-1 trading plan and leaves Brailo with 99,447 shares. The company has a strong financial health score and its stock has surged 48% in the past six months, with analysts maintaining positive outlooks and raising price targets following strong Q4 earnings.
Redlands Daily Facts: Local News, Sports and Things to Do - Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC) announced that its Board of Directors declared a quarterly cash dividend of $0.21 per share of Class A common stock. This dividend will be payable on September 15, 2025, to stockholders of record as of September 1, 2025. Premier, Inc. is a leading technology-driven healthcare improvement company headquartered in Charlotte, N.C.
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a technology-driven healthcare improvement company, announced that its Board of Directors has declared a quarterly cash dividend of $0.21 per share of Class A common stock. This dividend will be payable on September 15, 2025, to stockholders of record as of September 1, 2025. The company specializes in providing integrated data, analytics, supply chain solutions, and consulting services to healthcare providers.
Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals (Nasdaq: VRTX) has been recognized by Premier, Inc. as a 2025 Breakthroughs Innovation Celebration winner for its non-opioid pain treatment, JOURNAVX™ (suzetrigine). JOURNAVX is an oral, highly selective NaV1.8 pain signal inhibitor approved for adults with moderate-to-severe acute pain. This recognition highlights Vertex's commitment to providing innovative, non-opioid solutions to patients and its partnership with Premier aims to make JOURNAVX accessible to a broad network of healthcare providers.
Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals announced it has won a Premier, Inc. 2025 Breakthroughs Innovation Celebration award for JOURNAVX™ (suzetrigine), an oral, non-opioid treatment for moderate-to-severe acute pain. This recognition highlights JOURNAVX as a groundbreaking healthcare technology. The drug, approved by the FDA in January 2025, is a highly selective NaV1.8 pain signal inhibitor that offers effective pain relief without the addictive potential of opioids.
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC) announced that its Board of Directors has declared a quarterly cash dividend of $0.21 per share of Class A common stock. The dividend is payable no later than June 15, 2025, to stockholders of record as of June 1, 2025. Premier, Inc. is a technology-driven healthcare improvement company headquartered in Charlotte, N.C.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Premier, Inc. (PINC) And Encourages Investors to Reach Out
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential claims against Premier, Inc. (PINC) following the company's Q2 fiscal year 2025 financial results. Premier reported a decline in revenue, missed consensus estimates, and a significant GAAP net loss including an impairment charge. This news led to a 14.69% drop in Premier's stock price, and the firm is encouraging affected investors to come forward.
AllSpire Health Partners Selects Premier, Inc. as its National GPO
Premier, Inc. has been selected as the primary national GPO by AllSpire Health GPO, LLC, supporting over $3.5 billion in annual purchasing volume. This partnership will provide AllSpire members access to Premier’s national contract portfolio, supply chain services, and performance improvement technology to enhance operational efficiency and value. The collaboration aims to drive efficiencies, improve patient care, and streamline supply chain management for the 54 acute care hospitals within AllSpire Health GPO.
Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet
Alafair Biosciences, Inc. announced that its VersaWrap® Hydrogel Sheet has been awarded a national group purchasing agreement with Premier, Inc., effective July 1, 2024. This agreement allows Premier members access to special pricing for VersaWrap, an FDA-cleared medical device designed to reduce reoperations and improve patient outcomes by enabling tissue glide. Alafair Biosciences anticipates this will broaden VersaWrap's reach and contribute to continued year-over-year growth.
Pfizer Tornado Damage Threatens Tenuous US Drug Supply Chain
A tornado strike at a major Pfizer manufacturing facility in Rocky Mount, North Carolina, has prompted hospital drug buyers and healthcare service providers to assess the potential impact on the already fragile US drug supply chain. Premier Inc. and Vizient Inc. are collaborating with other drugmakers to increase production and manage inventory, as hundreds of medicines were already in short supply before the incident. This damage threatens to exacerbate existing drug shortages across the country.
Providence and Premier, Inc. Join CommonSpirit to Support the Development of the Healthcare Workforce
Providence and Premier Inc. are partnering with Dignity Health Global Education (DHGE), a CommonSpirit Health company, to address national healthcare workforce challenges. This collaboration aims to expand solutions for supporting the engagement and retention of healthcare professionals through quality education and development programs. The initiative seeks to stabilize the healthcare workforce amidst high turnover rates and rising hospital costs associated with attracting and retaining talent.
Qventus Announces $50 Million Growth Capital Round Led by THL and Strategic Partnership with Premier, Inc.
Qventus, a provider of AI-powered software for care operations, announced a $50 million growth investment led by Thomas H. Lee Partners (THL) and a strategic partnership with Premier, Inc. The funding and partnership aim to expand Qventus's technology to more hospitals and health systems across the U.S., enhancing its market presence and product vision. This initiative seeks to improve patient experience, alleviate healthcare professional burden, and deliver a clear return-on-investment through operational automation.
Perinatal Improvement Collaborative to Improve Outcomes for Mothers and Babies Across the Nation
Atrium Health announced its participation in the U.S. Department of Health and Human Services (HHS) Perinatal Improvement Collaborative, a large-scale, data-driven initiative involving over 200 hospitals nationwide. This collaborative aims to reduce preventable deaths and complications among mothers and babies by testing interventions and protocols using real-time data and performance improvement methodologies from Premier Inc. The initiative focuses on health equity, addressing disparities in birth outcomes, and tailoring care through comprehensive data analysis, linking outcomes between mothers and babies, and identifying social determinants of health to reduce risks.
Surgio Health Secures Contract Award With Premier, a Leading Group Purchasing Organization
Surgio Health has secured a systemwide contract award with Premier Inc., a major group purchasing organization, effective June 1. This partnership allows Premier's extensive membership of hospitals and healthcare providers to access Surgio's surgical logistics management platform at pre-negotiated terms. Surgio Health's CEO, Chris J. Stewart, highlights the contract as a confirmation of their platform's value in optimizing surgical asset management and workflow.
Former Premier CEO Susan DeVore talks retirement plans, what she's learned along the way
Premier Inc. CEO Susan DeVore is set to retire on June 30 after 18 years with the company. She has made a career out of improving health-care models and is preparing for her next chapter.
New CEO talks Premier's future, how firm is helping health care evolve and lessons learned during Covid
Premier Inc.'s new CEO, Michael Alkire, discussed the company's future steps, its role in evolving healthcare, and insights gained during the Covid-19 pandemic. He shared these perspectives in an interview with the Charlotte Business Journal, following his recent appointment and amid significant changes in the healthcare landscape.
Corporate Screening Selected as Exclusive Background Screening Supplier for Premier SURPASS Purchasing Program
Corporate Screening Services, a leading employment background screening provider, has been awarded a category-exclusive, national group purchasing agreement with Premier Inc.'s SURPASS program. This agreement grants SURPASS members access to Corporate Screening's background screening solutions, known for their proactive service and relationship-focused support. The partnership aims to provide Premier's highly dedicated members with pre-negotiated background check services, leveraging Corporate Screening's expertise in healthcare screening.
Longtime Premier CEO Susan DeVore stepping down this year
Premier Inc. CEO Susan DeVore announced she will step down effective May 1, 2021, after more than a decade in the role. The company made this announcement on Tuesday morning, February 2, 2021.
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC) announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of Class A common stock. The dividend is payable on March 15, 2021, to stockholders of record as of March 1, 2021. Premier is a healthcare improvement company that unites an alliance of over 4,100 U.S. hospitals and health systems.
Charlotte's Women In Business: Laura Doerre
Laura Doerre, Executive Vice President, General Counsel, and Chief Compliance Officer for Jeld-Wen Inc., has been recognized as a 2018 honoree in the Charlotte Business Journal's Women in Business awards program. This article highlights her achievement and affiliation with Jeld-Wen Inc.
User guide to Ballantyne Corporate Park: Coffee, lunch, fitness & happy hour (plus perks)
This article provides a user guide to Ballantyne Corporate Park, highlighting its amenities and attractions beyond just office buildings. It covers options for coffee, lunch, fitness, and happy hour, along with various perks available to tenants. The guide aims to show that the corporate park offers a vibrant experience beyond just work.
Premier, Inc. Announces Pricing of Initial Public Offering
Premier, Inc. announced the pricing of its initial public offering of 28,151,958 shares of Class A common stock at $27 per share. The shares are expected to begin trading on the NASDAQ Global Select Market under the ticker symbol "PINC" on September 26, 2013. J.P. Morgan Securities LLC, BofA Merrill Lynch, and Wells Fargo Securities, LLC are serving as joint book-running managers for the offering.
GPO: Premier eyes IPO worth up to $100M
Premier healthcare alliance is planning an initial public offering (IPO) worth up to $100 million, as stated in recent SEC filings. The group purchasing organization, which serves nearly 3,000 community hospitals and 100,000 alternate care sites, plans to trade on the NASDAQ Capital Market under the symbol ‘PNC’. Following the IPO, Premier intends to restructure its business to focus on supply-chain purchasing and consulting.
